Synthesis, Antibacterial and Antioxidant Evaluation of Novel 1-(5,7-Dichloro-1,3-benzoxazol-2-yl)-1H-pyrazolo[3,4-b]quinoline Derivatives

Table 4

Ferric reducing activity of compounds 8(a–f).

Compound	Ferric reducing activity of different concentrations (μg/mL) %
	25	50	100	200	400
8a	0.38	0.40	0.41	0.43	0.43
8b	0.27	0.28	0.31	0.31	0.32
8c	0.26	0.28	0.33	0.33	0.34
8d	0.32	0.36	0.37	0.38	0.38
8e	0.41	0.46	0.52	0.53	0.56
8f	0.42	0.47	0.53	0.55	0.59
Tannic acid	0.45	0.50	0.56	0.62	0.69